The management of mu-Drop are all industry veterans (Merck&Co., Boehringer Ingelheim, Medisize, Norton Fluid Systems, NPBI/Fresenius and a Compounding Pharmacy) and earlier responsible for innovative products. In 2011 they created mu-Drop to combine the strength of pharma, medical, process and pharmacy know-how to drive fanatically the improvement eye-care medication. The first result of the unique combination of know-how is a micro eye-drop to patients suffering from severe Dry-Eye-Syndrome.
In 2014 mu-Drop was nominated for ‘start-up of the year’.
In 2016 mu-Drop secured significant funds for development and manufacturing and entered into agreements to bring micro eye-drops to patients.
mu-Drop has a fanatic passion to improve the outcome of ophthalmic therapies and drive the quality of life of patients
mu-Drop believes that the platform technology will overcome significant unmet ophthalmic medical needs and improve, amongst other ophthalmic disorders, the outcome of glaucoma and dry-eye therapies and quality of life
Every new medicated eye drop product will be a micro drop because:
mu-Drop micro eye drops can be manufactured very efficiently, are 10 times smaller than classic eye drops and thus require 10 less medication. mu-Drop is licensing the technology to preferred partners.Contact us